MDxHealth (MDXH) Competitors

MDxHealth (NASDAQ:MDXH) and Personalis (NASDAQ:PSNL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation, community ranking and profitability.

Do analysts rate MDXH or PSNL?

MDxHealth presently has a consensus target price of $6.50, suggesting a potential upside of 271.43%. Personalis has a consensus target price of $7.80, suggesting a potential upside of 106.02%. Given MDxHealth's higher probable upside, equities research analysts clearly believe MDxHealth is more favorable than Personalis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MDxHealth	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Personalis	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media favor MDXH or PSNL?

In the previous week, Personalis had 3 more articles in the media than MDxHealth. MarketBeat recorded 5 mentions for Personalis and 2 mentions for MDxHealth. MDxHealth's average media sentiment score of 0.91 beat Personalis' score of 0.51 indicating that MDxHealth is being referred to more favorably in the media.

Company	Overall Sentiment
MDxHealth	Positive
Personalis	Positive

Does the MarketBeat Community believe in MDXH or PSNL?

Personalis received 110 more outperform votes than MDxHealth when rated by MarketBeat users. Likewise, 68.31% of users gave Personalis an outperform vote while only 55.56% of users gave MDxHealth an outperform vote.

Company	Underperform	Outperform
MDxHealth	Outperform Votes 15 55.56%	Underperform Votes 12 44.44%
Personalis	Outperform Votes 125 68.31%	Underperform Votes 58 31.69%

Which has more volatility & risk, MDXH or PSNL?

MDxHealth has a beta of 1.29, suggesting that its share price is 29% more volatile than the S&P 500. Comparatively, Personalis has a beta of 1.89, suggesting that its share price is 89% more volatile than the S&P 500.

Do insiders & institutionals have more ownership in MDXH or PSNL?

61.9% of Personalis shares are owned by institutional investors. 1.7% of MDxHealth shares are owned by insiders. Comparatively, 3.8% of Personalis shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Which has stronger earnings and valuation, MDXH or PSNL?

MDxHealth has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than MDxHealth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MDxHealth	$90.05M	0.92	-$43.10M	-$1.27	-1.38
Personalis	$84.61M	3.95	-$108.30M	-$1.37	-2.76

Is MDXH or PSNL more profitable?

MDxHealth has a net margin of -49.52% compared to Personalis' net margin of -104.52%. Personalis' return on equity of -66.07% beat MDxHealth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MDxHealth	-49.52%	-1,077.84%	-28.82%
Personalis	-104.52%	-66.07%	-41.34%

Summary

Personalis beats MDxHealth on 9 of the 17 factors compared between the two stocks.